# Jubilant Cadista Pharmaceuticals – FDA Inspection, Jan 15, 2025

Source: https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals/5b258395-a5e1-464c-948d-f9ba4d41d146
Source feed: FDA_Inspections

> FDA inspection 1257696 of Jubilant Cadista Pharmaceuticals, January 15, 2025. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257696
- Company Name: Jubilant Cadista Pharmaceuticals
- Inspection Date: 2025-01-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 5

## Related Documents

- FDA Inspection 1064090 - 2018-05-04
- FDA Inspection 1004522 - 2017-03-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/jubilant-cadista-pharmaceuticals/2ae8df29-3a63-4875-bd56-0858ac01db5e

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8